The study looks at the direct, indirect and mortality-related costs of 24 rare diseases across five ...
Read moreThe National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s Zej...
Read moreOn 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...
Read moreThe National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...
Read moreReimbursed spending by the CNAM on out-patient care (including care from general practitioners [GPs]...
Read moreThe Italian Medicines Agency (AIFA) has announced that Roche’s Evyrsdi (risdiplam) is reimbursed w...
Read moreThe CDF allows patients to access a new treatment while further data is collected on its clinical an...
Read moreIn a statement the ICR said that it welcomes some of the changes, but that it wants to “see furthe...
Read moreIn line with legislation published in the Official Journal (Journal Officiel) on 1st February 2022, ...
Read moreThe news comes after the health service negotiated a “significant confidential discount” to the ...
Read more